uPA-Silica-Particles (SP-uPA): A Novel Analytical System to Investigate uPA-uPAR Interaction and to Test Synthetic uPAR Antagonists as Potential Cancer Therapeutics-Reference-Cited by-同舟云学术

uPA-Silica-Particles (SP-uPA): A Novel Analytical System to Investigate uPA-uPAR Interaction and to Test Synthetic uPAR Antagonists as Potential Cancer Therapeutics

Published:2002-01-23 Issue:1 Volume:383 Page:
ISSN:1431-6730
Container-title:Biological Chemistry
language:
Short-container-title:

Author:

Guthaus Elke,Bürgle Markus,Schmiedeberg Niko,Hocke Stefan,Eickler Alexandra,Kramer Michael D.,Sweep C.G.J. Fred,Magdolen Viktor,Kessler Horst,Schmitt Manfred

Publisher

Walter de Gruyter GmbH

Subject

Clinical Biochemistry,Molecular Biology,Biochemistry

Link

https://www.degruyter.com/document/doi/10.1515/BC.2002.021/pdf

Reference45 articles.

1. The urokinase-type plasminogen activator system in cancer metastasis: A review

2. The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases.

3. Inhibition of the Interaction of Urokinase-Type Plasminogen Activator (uPA) with Its Receptor (uPAR) by Synthetic Peptides

4. Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enzyme-encapsulated silica nanoparticle for cancer chemotherapy;Journal of Nanoparticle Research;2012-03

2. Urokinase-type Plasminogen Activator (uPA) and its Receptor (uPAR): Development of Antagonists of uPA / uPAR Interaction and their Effects In Vitro and In Vivo;Current Pharmaceutical Design;2003-07-01

3. Protease Inhibitors Prevent Plasminogen-Mediated, But Not Pemphigus Vulgaris-Induced, Acantholysis in Human Epidermis;Biological Chemistry;2003-01-20

4. The Urokinase Receptor (uPAR, CD87) as a Target for Tumor Therapy: uPA-Silica Particles (SP-uPA) as a New Tool for Assessing Synthetic Peptides to interfere with uPA/uPA-Receptor Interaction;Molecular Staging of Cancer;2003

5. Synthesis, Solution Structure, and Biological Evaluation of Urokinase Type Plasminogen Activator (uPA)-Derived Receptor Binding Domain Mimetics;Journal of Medicinal Chemistry;2002-10-08